SolasCure Awarded £405K Innovate UK Biomedical Catalyst Grant to Advance Chronic Wound Care

From SolasCureMar 20 2024 SOLASCURE Ltd , a biotechnology company developing a novel treatment to transform chronic wound care, today announced it has been awarded a highly competitive Biomedical Catalyst grant for industry-led research and development from Innovate UK, the UK’s innovation agency.

SolasCure is one of 32 companies to be awarded the prestigious grant, which aims to support the development of solutions to significant health and healthcare challenges, out of 358 candidates that applied.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Breakthrough Catalyst Turns Sewage Into Clean EnergyScientists developed a catalyst that can purify sewage while generating hydrogen fuel, creating a potential revenue stream from wastewater treatment.
Source: OilandEnergy - 🏆 34. / 68 Read more »

Researchers Awarded $3.2 Million Grant to Study Treatment Resistance in Cutaneous MelanomaA team of investigators from UCLA Health and UAMS Winthrop P. Rockefeller Cancer Institute received a $3.2 million grant to study treatment resistance in cutaneous melanoma. The researchers aim to identify new ways to prevent and overcome resistance to targeted therapy in all sub-types of this aggressive form of skin cancer.
Source: NewsMedical - 🏆 19. / 71 Read more »